Ultrashort Oncologic Whole-Body [18F]FDG Patlak Imaging Using LAFOV PET

Joyce van Sluis, Johannes H. van Snick, Andor W.J.M. Glaudemans, Riemer H.J.A. Slart, Walter Noordzij, Adrienne H. Brouwers, Rudi A.J.O. Dierckx, Adriaan A. Lammertsma, Charalampos Tsoumpas, Ronald Boellaard
{"title":"Ultrashort Oncologic Whole-Body [18F]FDG Patlak Imaging Using LAFOV PET","authors":"Joyce van Sluis, Johannes H. van Snick, Andor W.J.M. Glaudemans, Riemer H.J.A. Slart, Walter Noordzij, Adrienne H. Brouwers, Rudi A.J.O. Dierckx, Adriaan A. Lammertsma, Charalampos Tsoumpas, Ronald Boellaard","doi":"10.2967/jnumed.124.267784","DOIUrl":null,"url":null,"abstract":"<p>Methods to shorten [<sup>18</sup>F]FDG Patlak PET imaging procedures ranging from 65–90 to 20–30 min after injection, using a population-averaged input function (PIF) scaled to patient-specific image-derived input function (IDIF) values, were recently evaluated. The aim of the present study was to explore the feasibility of ultrashort 10-min [<sup>18</sup>F]FDG Patlak imaging at 55–65 min after injection using a PIF combined with direct Patlak reconstructions to provide reliable quantitative accuracy of lung tumor uptake, compared with a full-duration 65-min acquisition using an IDIF. <strong>Methods:</strong> Patients underwent a 65-min dynamic PET acquisition on a long-axial-field-of-view (LAFOV) Biograph Vision Quadra PET/CT scanner. Subsequently, direct Patlak reconstructions and image-based (with reconstructed dynamic images) Patlak analyses were performed using both the IDIF (time to relative kinetic equilibrium between blood and tissue concentration (t*) = 30 min) and a scaled PIF at 30–60 min after injection. Next, direct Patlak reconstructions were performed on the system console using only the last 10 min of the acquisition, that is, from 55 to 65 min after injection, and a scaled PIF using maximum crystal ring difference settings of both 85 and 322. Tumor lesion and healthy-tissue uptake was quantified and compared between the differently obtained parametric images to assess quantitative accuracy. <strong>Results:</strong> Good agreement was obtained between direct- and image-based Patlak analyses using the IDIF (t* = 30 min) and scaled PIF at 30–60 min after injection, performed using the different approaches, with no more than 8.8% deviation in tumor influx rate value (<em>K<sub>i</sub></em>) (mean difference ranging from −0.0022 to 0.0018 mL/[min × g]). When direct Patlak reconstruction was performed on the system console, excellent agreement was found between the use of a scaled PIF at 30–60 min after injection versus 55–65 min after injection, with 2.4% deviation in tumor <em>K<sub>i</sub></em> (median difference, −0.0018 mL/[min × g]; range, −0.0047 to 0.0036 mL/[min × g]). For different maximum crystal ring difference settings using the scan time interval of 55–65 min after injection, only a 0.5% difference (median difference, 0.0000 mL/[min × g]; range, −0.0004 to 0.0013 mL/[min × g]) in tumor <em>K<sub>i</sub></em> was found. <strong>Conclusion:</strong> Ultrashort whole-body [<sup>18</sup>F]FDG Patlak imaging is feasible on an LAFOV Biograph Vision Quadra PET/CT system without loss of quantitative accuracy to assess lung tumor uptake compared with a full-duration 65-min acquisition. The ultrashort 10-min direct Patlak reconstruction with PIF allows for its implementation in clinical practice.</p>","PeriodicalId":22820,"journal":{"name":"The Journal of Nuclear Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Nuclear Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2967/jnumed.124.267784","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Methods to shorten [18F]FDG Patlak PET imaging procedures ranging from 65–90 to 20–30 min after injection, using a population-averaged input function (PIF) scaled to patient-specific image-derived input function (IDIF) values, were recently evaluated. The aim of the present study was to explore the feasibility of ultrashort 10-min [18F]FDG Patlak imaging at 55–65 min after injection using a PIF combined with direct Patlak reconstructions to provide reliable quantitative accuracy of lung tumor uptake, compared with a full-duration 65-min acquisition using an IDIF. Methods: Patients underwent a 65-min dynamic PET acquisition on a long-axial-field-of-view (LAFOV) Biograph Vision Quadra PET/CT scanner. Subsequently, direct Patlak reconstructions and image-based (with reconstructed dynamic images) Patlak analyses were performed using both the IDIF (time to relative kinetic equilibrium between blood and tissue concentration (t*) = 30 min) and a scaled PIF at 30–60 min after injection. Next, direct Patlak reconstructions were performed on the system console using only the last 10 min of the acquisition, that is, from 55 to 65 min after injection, and a scaled PIF using maximum crystal ring difference settings of both 85 and 322. Tumor lesion and healthy-tissue uptake was quantified and compared between the differently obtained parametric images to assess quantitative accuracy. Results: Good agreement was obtained between direct- and image-based Patlak analyses using the IDIF (t* = 30 min) and scaled PIF at 30–60 min after injection, performed using the different approaches, with no more than 8.8% deviation in tumor influx rate value (Ki) (mean difference ranging from −0.0022 to 0.0018 mL/[min × g]). When direct Patlak reconstruction was performed on the system console, excellent agreement was found between the use of a scaled PIF at 30–60 min after injection versus 55–65 min after injection, with 2.4% deviation in tumor Ki (median difference, −0.0018 mL/[min × g]; range, −0.0047 to 0.0036 mL/[min × g]). For different maximum crystal ring difference settings using the scan time interval of 55–65 min after injection, only a 0.5% difference (median difference, 0.0000 mL/[min × g]; range, −0.0004 to 0.0013 mL/[min × g]) in tumor Ki was found. Conclusion: Ultrashort whole-body [18F]FDG Patlak imaging is feasible on an LAFOV Biograph Vision Quadra PET/CT system without loss of quantitative accuracy to assess lung tumor uptake compared with a full-duration 65-min acquisition. The ultrashort 10-min direct Patlak reconstruction with PIF allows for its implementation in clinical practice.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用 LAFOV PET 进行超短肿瘤全身[18F]FDG 帕特里克成像
最近,研究人员评估了将[18F]FDG Patlak PET成像程序从注射后65-90分钟缩短到20-30分钟的方法,该方法使用的是按患者特异性图像衍生输入函数(IDIF)值缩放的群体平均输入函数(PIF)。本研究旨在探索注射后 55-65 分钟内使用 PIF 结合直接 Patlak 重建进行 10 分钟超短 [18F]FDG Patlak 成像的可行性,与使用 IDIF 进行 65 分钟全长采集相比,后者能提供可靠的肺部肿瘤摄取定量准确性。方法:患者在长轴视场(LAFOV)Biograph Vision Quadra PET/CT扫描仪上进行65分钟动态PET采集。随后,使用 IDIF(血液和组织浓度达到相对动力学平衡的时间 (t*) = 30 分钟)和注射后 30-60 分钟的缩放 PIF 进行直接 Patlak 重建和基于图像(重建动态图像)的 Patlak 分析。接下来,在系统控制台上仅使用采集的最后 10 分钟(即注射后 55 分钟至 65 分钟)进行直接 Patlak 重建,并使用 85 和 322 两种最大晶体环差设置进行缩放 PIF。对肿瘤病灶和健康组织的摄取进行量化,并对不同参数图像进行比较,以评估量化的准确性。结果:使用 IDIF(t* = 30 分钟)和注射后 30-60 分钟的缩放 PIF 进行的直接 Patlak 分析和基于图像的 Patlak 分析之间取得了良好的一致性,肿瘤摄取率值 (Ki) 的偏差不超过 8.8%(平均差异范围为 -0.0022 至 0.0018 mL/[min×g])。在系统控制台上直接进行帕特拉克重建时,发现在注射后 30-60 分钟与注射后 55-65 分钟使用比例 PIF 之间具有极好的一致性,肿瘤 Ki 偏差为 2.4%(中位数差异为 -0.0018 mL/[min×g];范围为 -0.0047 至 0.0036 mL/[min×g])。在注射后 55-65 分钟的扫描时间间隔内,使用不同的最大晶体环差异设置,发现肿瘤 Ki 仅有 0.5% 的差异(中位数差异,0.0000 mL/[min×g];范围,-0.0004 至 0.0013 mL/[min×g])。结论在LAFOV Biograph Vision Quadra PET/CT系统上进行超短全身[18F]FDG Patlak成像,与65分钟的全长采集相比,不会降低评估肺部肿瘤摄取的定量准确性。超短的 10 分钟直接 Patlak 重建与 PIF 使其能够应用于临床实践。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Precautions to Consider in the Analysis of Prognostic and Predictive Indices Head-to-Head Comparison of [68Ga]Ga-NOTA-RM26 and [18F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study [18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy MIRD Pamphlet No. 31: MIRDcell V4—Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1